Pharmac to change brand of fulvestrant injection for New Zealanders with breast cancer
Source: PHARMAC Pharmac has confirmed a change in the funded brand of fulvestrant injection, a medicine used to treat certain types of breast cancer. From 1 December 2025, the funded brand will change to Fulvestrant EVER Pharma (InterPharma). Faslodex will be delisted on 1 May 2026, and Fulvestrant EVER Pharma will then hold Principal Supply … Read more